Status:
COMPLETED
Cerebral Toxoplasmosis and AIDS
Lead Sponsor:
University Hospital, Limoges
Conditions:
Cerebral Toxoplasmosis
AIDS
Eligibility:
All Genders
18+ years
Brief Summary
With a HIV incidence much higher in the DFA than in European French territory, this disease is a major public health problem in these areas, especially in French Guiana. Cerebral toxoplasmosis is a p...
Eligibility Criteria
Inclusion
- Adult patient (\> 18 years)
- Patient being informed and accepting to participate in the study with signature of informed consent
- HIV positive serology
- Clinical and radiological suspicion of cerebral toxoplasmosis justifying the start of specific antitoxoplasmic therapy
Exclusion
- Protected patient
- Patient uncovered by social insurance
- Specific antitoxoplasmic therapy already initiated since 72h or more
Key Trial Info
Start Date :
June 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2013
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT00803621
Start Date
June 1 2009
End Date
December 1 2013
Last Update
July 5 2019
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Service des Maladies Infectieuses - CHU de Pointe à Pitre
Pointe à Pitre, Guadeloupe, France
2
Dermatologie et CISIH- CH Andrée Rosemon
Guyane-Française, Guyane-Française, France
3
Médecine- CH Ouest Guyanais
Guyane-Français, Guyane-Français, France
4
Services Maladies Infectieuses et Tropicales- CHU Fort-de-France
Fort-de-France, France